Near-infrared Dye Marking for Thoracoscopic Resection of Small-sized Pulmonary Nodules: Comparison of Percutaneous and Bronchoscopic Injection Techniques
Overview
Authors
Affiliations
Background: Minimally invasive video-assisted thoracoscopic surgery for small-sized pulmonary nodules is challenging, and image-guided preoperative localisation is required. Near-infrared indocyanine green fluorescence is capable of deep tissue penetration and can be distinguished regardless of the background colour of the lung; thus, indocyanine green has great potential for use as a near-infrared fluorescent marker in video-assisted thoracoscopic surgery.
Methods: Thirty-seven patients with small-sized pulmonary nodules, who were scheduled to undergo video-assisted thoracoscopic wedge resection, were enrolled in this study. A mixture of diluted indocyanine green and iopamidol was injected into the lung parenchyma as a marker, using either computed tomography-guided percutaneous or bronchoscopic injection techniques. Indications and limitations of the percutaneous and bronchoscopic injection techniques for marking nodules with indocyanine green fluorescence were examined and compared.
Results: In the computed tomography-guided percutaneous injection group (n = 15), indocyanine green fluorescence was detected in 15/15 (100%) patients by near-infrared thoracoscopy. A small pneumothorax occurred in 3/15 (20.0%) patients, and subsequent marking was unsuccessful after a pneumothorax occurred. In the bronchoscopic injection group (n = 22), indocyanine green fluorescence was detected in 21/22 (95.5%) patients. In 6 patients who underwent injection marking at 2 different lesion sites, 5/6 (83.3%) markers were successfully detected.
Conclusion: Either computed tomography-guided percutaneous or bronchoscopic injection techniques can be used to mark pulmonary nodules with indocyanine green fluorescence. Indocyanine green is a safe and easily detectable fluorescent marker for video-assisted thoracoscopic surgery. Furthermore, the bronchoscopic injection approach enables surgeons to mark multiple lesion areas with less risk of causing a pneumothorax.
Trial Registration: UMIN-CTR R000027833 accepted by ICMJE. Registered 5 January 2013.
Dai B, Yu A, Zhao G, Wang Y, Zhou Y, Ni K J Thorac Dis. 2024; 16(10):7192-7203.
PMID: 39552905 PMC: 11565355. DOI: 10.21037/jtd-24-1502.
Gomez-Hernandez M, Rivas Duarte C, Fernandez Garcia-Hierro J, Fuentes M, Colmenares O, Barreda C Front Surg. 2024; 11:1482120.
PMID: 39403684 PMC: 11471733. DOI: 10.3389/fsurg.2024.1482120.
Spatial lung imaging in clinical and translational settings.
Mahmutovic Persson I, Bozovic G, Westergren-Thorsson G, Rolandsson Enes S Breathe (Sheff). 2024; 20(3):230224.
PMID: 39360023 PMC: 11444490. DOI: 10.1183/20734735.0224-2023.
McCullough M, Muller M, Egan T, Buckner G Bioengineering (Basel). 2024; 11(5).
PMID: 38790285 PMC: 11118073. DOI: 10.3390/bioengineering11050417.
Jeon O, Kim K, Kim C, Choi B, Lee J, Kim B Int J Surg. 2024; 110(8):4708-4715.
PMID: 38752517 PMC: 11325942. DOI: 10.1097/JS9.0000000000001581.